se of Vyoshadi Guggulu and Thyroxine Sodium Tablet in management of Hypothyroidism.
Phase 2
- Conditions
- Health Condition 1: E039- Hypothyroidism, unspecified
- Registration Number
- CTRI/2024/02/063328
- Lead Sponsor
- Dr Haresh Dattatray Sable
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Serum Ultrasensitive level 5 – 15 micro IU/ML
2.Freshly diagnosed cases of Hypothyroidism.
3.Subject having one or more classical symptoms.
4.Patient of either gender.
5.Age 18 years and 40 years.
Exclusion Criteria
1.Immunocompromised patients or patients on immunocompressive drugs .
2.Patients suffering from life threatening diseases.
3.Pregnancy and lactating mother.
4.K/C/O Thyroid Neoplasia.
5.Progressive cases of Myxoedema coma.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method